2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with Blepharoptosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blendy, JA; Forcelli, PA; Kellar, KJ; Lee, BG; Olson, TT; Turner, JR; Xiao, Y; Xie, T | 1 |
1 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Blepharoptosis
Article | Year |
---|---|
Anxiolytic- and antidepressant-like effects of the methadone metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP).
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Blepharoptosis; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Male; Maze Learning; Mice; Mice, Inbred C57BL; Motor Activity; Naloxone; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Swimming; Time Factors; Tritium | 2016 |